This performance contributes to Humana’s impressive ... potentially leading to a significant re-rating of Humana’s stock as investors factor in improved growth prospects and reduced regulatory ...

Humana (NYSE:HUM) experienced a 3% price increase last week, which may have been influenced by its recent partnership with Mercy to open new primary care clinics for seniors. This expansion addresses ...

According to InvestingPro data, analyst targets range from $244 to $402, with the stock currently ... to improve its financial performance. In other recent news, Humana has expressed support ...

Humana faces significant earnings headwinds due to CMS reforms, star rating downgrades, and potential Medicaid clawbacks. Learn more about HUM stock here.

Humana’s stock performance and market strategies continue to be closely monitored by investors and analysts, with particular attention to how the company navigates industry challenges. In other recent ...

Raymond (NSE:RYMD) James has upgraded Humana’s stock rating from Market Perform to Outperform, setting a new price target of $315, citing the company’s strong performance and favorable drug mix.

In a report released today, David Windley from Jefferies maintained a Hold rating on Humana (HUM – Research Report), with a price target of $244.00. The company’s shares close ...

Healthcare conglomerate CVS Health CVS formed its Health Services segment through a realignment tied to a new operating model ...

potentially leading to disappointment among investors and downward pressure on the stock price. If Humana succeeds in improving its Medicare Advantage star ratings, it could lead to substantial ...

As Trump's sweeping tax-cut and spending bill marches forward, analysts examine how his broad-ranging policies could turn the fortunes of US companies.

Cigna has seen strong stock performance due to its strategic integration ... exceeding Wall Street forecasts of $60.8 billion. CI’s rival, Humana Inc. (HUM) shares lagged behind the stock ...